CVS Health Co. (NYSE:CVS) Holdings Decreased by Stoneridge Investment Partners LLC

Stoneridge Investment Partners LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 23.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 55,355 shares of the pharmacy operator's stock after selling 16,814 shares during the period. CVS Health accounts for approximately 1.3% of Stoneridge Investment Partners LLC's investment portfolio, making the stock its 25th biggest position. Stoneridge Investment Partners LLC's holdings in CVS Health were worth $3,481,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cullinan Associates Inc. raised its position in shares of CVS Health by 43.8% in the third quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator's stock valued at $7,125,000 after buying an additional 37,395 shares during the last quarter. Deerfield Management Company L.P. Series C acquired a new position in shares of CVS Health during the 2nd quarter worth approximately $57,584,000. CX Institutional increased its holdings in shares of CVS Health by 698.0% in the third quarter. CX Institutional now owns 74,609 shares of the pharmacy operator's stock valued at $4,691,000 after purchasing an additional 65,259 shares during the last quarter. Susquehanna Fundamental Investments LLC boosted its stake in CVS Health by 27.9% during the second quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator's stock worth $39,302,000 after buying an additional 145,158 shares during the last quarter. Finally, AustralianSuper Pty Ltd increased its stake in shares of CVS Health by 11.0% in the 3rd quarter. AustralianSuper Pty Ltd now owns 1,537,791 shares of the pharmacy operator's stock worth $96,696,000 after acquiring an additional 151,901 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on CVS shares. Cantor Fitzgerald reissued a "neutral" rating and issued a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Wells Fargo & Company dropped their price target on shares of CVS Health from $61.00 to $60.00 and set an "equal weight" rating for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a report on Friday, August 9th. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 8th. Finally, Barclays reduced their target price on CVS Health from $82.00 to $75.00 and set an "overweight" rating for the company in a report on Wednesday, October 23rd. Nine research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $73.11.

CVS Health Price Performance

CVS stock traded up $0.69 during trading on Tuesday, hitting $55.34. The stock had a trading volume of 10,987,539 shares, compared to its average volume of 11,175,767. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The stock has a market cap of $69.62 billion, a price-to-earnings ratio of 9.72, a price-to-earnings-growth ratio of 0.82 and a beta of 0.55. The company's 50 day moving average price is $59.58 and its two-hundred day moving average price is $59.39. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period last year, the company earned $2.21 EPS. The firm's quarterly revenue was up 2.6% on a year-over-year basis. On average, sell-side analysts forecast that CVS Health Co. will post 6.41 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.81%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio is currently 47.33%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.